ZBH - Premarket analyst action - healthcare October, 16 2018 07:49 AM Zimmer Biomet Holdings Inc. Abbott (NYSE:ABT) initiated with Overweight rating and $80 (16% upside) price target at Barclays. More news on: Abbott Laboratories, Arbutus Biopharma Corp, Avanos Medical, Inc., Healthcare stocks news, Stocks on the move, , Read more ...